Blood serum antibody analysis and long-term follow-up of patients treated with recombinant human bone morphogenetic protein-2 in the lumbar spine. [electronic resource]
Producer: 20120330Description: 2158-67 p. digitalISSN:- 1528-1159
- Animals
- Antibodies -- blood
- Antibodies, Neutralizing -- blood
- Bone Morphogenetic Protein 2 -- adverse effects
- Cattle
- Collagen Type I -- immunology
- Enzyme-Linked Immunosorbent Assay -- methods
- Female
- Follow-Up Studies
- Humans
- Intervertebral Disc -- pathology
- Intervertebral Disc Degeneration -- blood
- Longitudinal Studies
- Lumbar Vertebrae -- pathology
- Male
- Outcome Assessment, Health Care
- Prospective Studies
- Randomized Controlled Trials as Topic
- Recombinant Proteins -- adverse effects
- Spinal Fusion -- methods
- Time Factors
- Transforming Growth Factor beta -- adverse effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.